Latest filing published 13 Nov 2023 for Nextgen Healthcare, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jeffrey d. Linton (senior executive) discloses dealings in 2 companies, chiefly Nextgen Healthcare, Inc. and Sequenom Inc. The record holds 18 filings, for trades running from 10 February 2016 to 9 November 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 13 November 2023, the filings show a transaction in Nextgen Healthcare, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations